PROSPECTS AND OPPORTUNITIES
Moderate growth potential in value terms
Sales of analgesics are expected to continue growing in the forecast period, driven by the rising acceptance of self-medication, the high penetration rate of pharmacies and the strength of national brands. Accessible retail prices will be boosted by the high volume of generic options available in Brazil.
Opella Healthcare Group SAS invests heavily
In a mature category where there is widespread availability of generic drugs at an accessible value, companies are betting on differentiation beyond price as a way to retain and gain consumers. With the heavy publicity investment behind Dorflex Max by Opella Healthcare Group SAS in recent years, the player has maintained its position as one of the most important players in the local analgesics market.
Competition between pharmacy and supermarket channel is set to intensify
The Brazilian senate’s health commission recently approved a project that enables supermarkets to have a dedicated in-store space in supermarkets. If approved, the move that could broaden public access to OTC drugs, including analgesics, leading to a decrease in average prices as competition opens up.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Brazil with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Brazil, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Brazil report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Brazil?
- Which are the leading brands in Analgesics in Brazil?
- How are products distributed in Analgesics in Brazil?
- How has the regulatory and operating environment for Analgesics changed in Brazil?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Analgesics in Brazil - Category analysis
KEY DATA FINDINGS
Steady pace of growth for analgesics
Sanofi-Aventis Farmacêutica continues to gain ground
Pharmacies remain the dominant channel
Moderate growth potential in value terms
Opella Healthcare Group SAS invests heavily
Competition between pharmacy and supermarket channel is set to intensify
Consumer Health in Brazil - Industry Overview
Consumer Health in 2025: The big picture
Key trends in 2025
Competitive landscape
Channel developments
What next for Consumer Health?
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!